These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Type I diabetes mellitus in childhood and adolescence].
    Author: Herwig J.
    Journal: Z Arztl Fortbild Qualitatssich; 1997 Jun; 91(3):233-42. PubMed ID: 9312428.
    Abstract:
    Type I diabetes, the most common endocrinological disease in children and adolescents, is nowadays considered to be a genetically linked autoimmune disease. Clinical progression is divided into 3 phases: initial, remission and post-remission. Therapy consists of ketoacidotic compensation (when necessary), initial insulin dose adjustment, an organised education programme, and conventional insulin treatment with a mixture of normal and long-acting human insulins. Older children and adolescents (from age 12, or better, from age 14) are mostly treated with intensive conventional insulin therapy (ICT). The necessary long-term care of children and adolescents with diabetes should be carried out by a pediatric diabetic team. This team is in the position to recognise the special age-related problems in these patients and, based on adequate experience, can guarantee the best possible treatment. The aim must be the optimal, virtually near-normoglycaemic metabolic control already in childhood so as to avoid the threat of diabetic complications or at least to delay their onset.
    [Abstract] [Full Text] [Related] [New Search]